The activation of HER2 signaling pathways is mainly responsible for cellular proliferation and cell survival phenomena, which are regarded as dominant drivers that cause tumor development and progression in nearly 85% of BC cases [26]. This evidence concerns the gene ERBB2 and breast cancer.